We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Reata Pharmaceuticals Inc | NASDAQ:RETA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 172.36 | 189.75 | 172.36 | 0 | 01:00:00 |
1. Name and Address of Reporting Person * ROSE WILLIAM | 2. Issuer Name and Ticker or Trading Symbol REATA PHARMACEUTICALS INC [ RETA ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner _____ Officer (give title below) __X__ Other (specify below) Member of 10% owner group |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Class A common stock | 11/8/2019 | C | 15869 | A | (1) | 29386 | D (2) | |||
Class A common stock | 11/18/2019 | S | 400 | D | $205.10 | 28986 | D (2) | |||
Class A common stock | 11/18/2019 | S | 600 | D | $200.00 | 28386 | D (2) | |||
Class A common stock | 11/19/2019 | S | 2000 | D | $210.00 | 26386 | D (2) | |||
Class A common stock | 11/20/2019 | S | 591 | D | $215.89 | 25795 | D (2) | |||
Class A common stock | 11/20/2019 | S | 2000 | D | $210.00 | 23795 | D (2) | |||
Class A common stock | 11/20/2019 | S | 2000 | D | $211.27 | 21795 | D (2) | |||
Class A common stock | 11/20/2019 | S | 2000 | D | $215.32 | 19795 | D (2) | |||
Class A common stock | 11618 | D (3) | ||||||||
Class A common stock | 879281 | I | By trust (4) | |||||||
Class A common stock | 7886 | I | See Footnote (5) | |||||||
Class A common stock | 20 | I | By trust (6) | |||||||
Class A common stock | 45 | I | By trust (7) | |||||||
Class A common stock | 29 | I | See Footnote (8) | |||||||
Class A common stock | 180909 | I | By Montrose (9) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Class B common stock | (1) | 11/8/2019 | C | 15869 | (1) | (1) | Class A common stock | 15869 | $0.00 | 0 | D (2) |
Remarks: The reporting persons may be deemed to be members of a group with other affiliated entities that collectively are 10% owners, which group includes William E. Rose, Evelyn P. Rose, Evelyn P. Rose Fidelity Rollover IRA, Evelyn Potter Rose Survivor's Trust, Charles Henry Rose 2001 Trust, John William Rose 2002 Trust, Charles E. Gale, Charles E. Gale Fidelity Rollover IRA, Montrose Investments I, L.P. and Montrose Investments GP, LLC (collectively, the "Affiliated Rose Reporting Persons"). The reporting persons disclaim the existence of a group and disclaim beneficial ownership of any securities held by the other Affiliated Rose Reporting Persons, except to the extent of their respective pecuniary interests therein. |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
ROSE WILLIAM 3963 MAPLE AVENUE, SUITE 200 DALLAS, TX 75219 | X | X | Member of 10% owner group | ||
Montrose Investments I, L.P. 3963 MAPLE AVENUE, SUITE 200 DALLAS, TX 75219 | Member of 10% owner group | ||||
Montrose Investments GP, LLC 3963 MAPLE AVENUE, SUITE 200 DALLAS, TX 75219 | Member of 10% owner group | ||||
Gale Charles E. 3963 MAPLE AVENUE, SUITE 200 DALLAS, TX 75219 | X | Member of 10% owner group | |||
Charles E. Gale Fidelity Rollover IRA 3963 MAPLE AVENUE, SUITE 200 DALLAS, TX 75219 | Member of 10% owner group | ||||
Rose Evelyn P. 3963 MAPLE AVENUE, SUITE 200 DALLAS, TX 75219 | Member of 10% owner group | ||||
Evelyn P. Rose Fidelity Rollover IRA 3963 MAPLE AVENUE, SUITE 200 DALLAS, TX 75219 | Member of 10% owner group | ||||
Evelyn Potter Rose Survivor's Trust 3963 MAPLE AVENUE, SUITE 200 DALLAS, TX 75219 | Member of 10% owner group |
Signatures | ||
/s/ Charles E. Gale, Attorney-In-Fact for William E. Rose | 12/5/2019 | |
**Signature of Reporting Person | Date | |
/s/ Charles E. Gale, Attorney-In-Fact for Montrose Investments I, L.P. | 12/5/2019 | |
**Signature of Reporting Person | Date | |
/s/ Charles E. Gale, Attorney-In-Fact for Montrose Investments GP, LLC | 12/5/2019 | |
**Signature of Reporting Person | Date | |
/s/ Charles E. Gale | 12/5/2019 | |
**Signature of Reporting Person | Date | |
/s/ Charles E. Gale, Authorized Signatory for the Charles E. Gale Fidelity Rollover IRA | 12/5/2019 | |
**Signature of Reporting Person | Date | |
/s/ Charles E. Gale, Attorney-In Fact for Evelyn P. Rose | 12/5/2019 | |
**Signature of Reporting Person | Date | |
/s/ Charles E. Gale, Authorized Signatory for the Evelyn P. Rose Fidelity Rollover IRA | 12/5/2019 | |
**Signature of Reporting Person | Date | |
/s/ Charles E. Gale, Trustee and Attorney-In-Fact for the Evelyn Potter Rose Survivor's Trust | 12/5/2019 | |
**Signature of Reporting Person | Date |
1 Year Reata Pharmaceuticals Chart |
1 Month Reata Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions